Home

IGVFFI9896DZYL

preview
validated
This object is in preview status. Metadata is subject to change until this object is released.
File Set
IGVFDS4103BJLT(prime editing Variant-EFFECTS)
Summary
R2 reads from sequencing run 1
File Format
fastq
Content Type
reads
Aliases
jesse-engreitz:240426S024-PPIFenhancervalidation-THP1_Amp_PPIF_enhancer-THP1-PE2_Exp4_NegControl-PCRrep2_R2
md5sum
78de7b2ef80d47097ee4bd37c85cb38c
Content MD5sum
2849f22175aac1571621528cf8f9c3d4
File Size
9.6 MB
Submitted File Name
240426S024-Enhancer-THP1-PPIF_Enhancer_val_guides-Amp_PPIF_enhancer-BioRep1-FFrep1-BinNeg-PCRrep2_S816_R2_001.fastq.gz

Sequencing Details

Sequencing Platform
Illumina NovaSeq X
Sequencing Run
1
Illumina Read Type
R2
Index
TGTAATCA:CTGCTTCC
Average Read Length
151
Read Count
510024

Samples

1 item
Accession
Type
Sample Terms
Summary
InVitroSystem
THP-1 cell line, male, Homo sapiens modified with CRISPR prime editing Sp-nCas9-M-MLV RT (PE2)

Files Derived From This File

1 item
Accession
File Format
Content Type
Summary
Lab
File Size
Upload Status
tsv
variant effects
variant effects
Jesse Engreitz, Stanford
916 B
validated

Attribution

Award
HG011972
Principal Investigator(s)
Contact P.I.
Jesse Engreitz
Lab
Jesse Engreitz, Stanford